Premium Nahrungsergänzungsmittel | artgerecht

Pentraxin 3 (PTX3) – Inflammatory Biomarker Explained

Pentraxin 3 (PTX3) is an inflammatory biomarker of the innate immune system. Levels rise during infections, tissue injury, and cardiovascular disease.

Regular tips about health Regular tips about health

Things worth knowing about "Pentraxin 3"

Pentraxin 3 (PTX3) is an inflammatory biomarker of the innate immune system. Levels rise during infections, tissue injury, and cardiovascular disease.

What is Pentraxin 3?

Pentraxin 3 (PTX3) is a soluble protein belonging to the long pentraxin family of the innate immune system. It serves as an important biomarker for inflammation and tissue damage. Unlike the better-known C-reactive protein (CRP), which is mainly produced in the liver, PTX3 is synthesized locally at sites of inflammation — including in dendritic cells, macrophages, endothelial cells, and smooth muscle cells.

Biological Function and Mechanism of Action

PTX3 plays a central role in innate immune defense. It recognizes pathogens and damaged cells, and activates the complement system to help eliminate threats. Key functions include:

Opsonization: PTX3 binds to bacteria, fungi, and other pathogens, facilitating their recognition and clearance by immune cells.
Complement Activation: PTX3 activates and modulates parts of the complement system, supporting the immune response.
Tissue Repair: PTX3 is involved in regulating wound healing and extracellular matrix remodeling.
Angiogenesis Inhibition: PTX3 can inhibit the growth of new blood vessels, which is relevant in tumor and inflammatory processes.

Clinical Relevance as a Biomarker

PTX3 is studied in medical research and diagnostics as a biomarker for a range of conditions. Elevated PTX3 levels in the blood can indicate the following:

Infectious Diseases

During severe bacterial or fungal infections, including sepsis, PTX3 levels rise rapidly — often faster than CRP. This positions PTX3 as a potentially earlier marker of severe infection.

Cardiovascular Diseases

Studies show that elevated PTX3 levels are associated with a higher risk of myocardial infarction, heart failure, and atherosclerosis. PTX3 is produced locally within atherosclerotic plaques by vascular wall cells, making it a marker of local vascular inflammation.

Autoimmune Diseases

In conditions such as systemic lupus erythematosus, rheumatoid arthritis, and other systemic inflammatory diseases, PTX3 levels are frequently elevated and correlate with disease activity.

COVID-19 and Respiratory Illness

During the COVID-19 pandemic, PTX3 was investigated as a marker of disease severity. High PTX3 levels were associated with an increased risk of intensive care admission and mortality.

Kidney Disease

Elevated PTX3 levels have also been reported in chronic kidney disease and following kidney transplantation, where they may reflect organ damage or rejection episodes.

Measurement and Diagnostics

PTX3 is measured from a blood sample using an ELISA assay. In healthy adults, normal PTX3 concentrations are typically below 2 ng/ml. During severe infections or inflammatory states, values can exceed 200 ng/ml. PTX3 is currently primarily a research biomarker but is increasingly being used in clinical settings.

Difference from CRP

Although PTX3 and CRP both belong to the pentraxin family, they differ in important ways:

CRP is mainly produced in the liver; PTX3 is synthesized directly at the site of inflammation.
PTX3 rises more rapidly during infection than CRP.
PTX3 is considered a more specific marker for local tissue inflammation and certain pathogens, particularly fungi.

References

Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annual Review of Immunology. 2005;23:337-366.
Mairuhu AT, Peri G, Setiati TE, et al. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. Journal of Medical Virology. 2005;76(4):547-552.
Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein and pentraxin-3 in patients with acute coronary syndrome: association with severity and prognosis. Thrombosis Research. 2013;132(3):e83-e87.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category